Fatty acids in cord blood plasma, the relation to soluble CD23 and subsequent atopy.

Prostaglandins Leukot Essent Fatty Acids

Department of Pediatrics, Stavanger University Hospital, Stavanger, Norway.

Published: January 2008

Atopy is suggested to be linked to the balance between levels of n-6 and n-3 series of long chain polyunsaturated fatty acids (PUFAs) in the diet. In a nested case-control study, levels of fatty acids, IgE and soluble low affinity IgE receptor (sCD23) were measured in cord blood in 35 children who subsequently developed allergic sensitisation and atopic dermatitis before the age of 3, and similarly in 35 matched children without a history of atopy. We found a tendency to lower levels of the n-3 PUFAs eicosapentaenoic acid (EPA) and alpha-linolenic acid (ALA) in the cord blood plasma of atopics compared to non-atopics. Levels of sCD23 were negatively correlated to levels of n-3 series of PUFAs and n-9 eicosenoic acid, and levels of n-9 eicosenoic acid was negatively correlated to levels of IgE. There was no association between the levels of sCD23 and n-6 PUFAs. Lower levels of n-3 PUFAs in cord blood may be associated with the development of atopy in children. A possible mechanism may be through the regulation of CD23, thereby influencing IgE synthesis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.plefa.2007.10.008DOI Listing

Publication Analysis

Top Keywords

cord blood
16
fatty acids
12
levels n-3
12
levels
9
blood plasma
8
n-3 series
8
lower levels
8
n-3 pufas
8
levels scd23
8
negatively correlated
8

Similar Publications

Mucopolysaccharidosis type I (MPS I) is a metabolic disorder characterized by a deficiency in α-l-iduronidase (IDUA), leading to impaired glycosaminoglycan degradation. Current approved treatments seek to restore IDUA levels via enzyme replacement therapy (ERT) and/or hematopoietic stem cell transplantation (HSCT). The effectiveness of these treatment strategies in preventing neurodegeneration is limited due to the inability of ERT to penetrate the blood-brain barrier (BBB) and HSCT's limited CNS reconstitution of IDUA levels.

View Article and Find Full Text PDF

Transient hypothyroidism in a neonate following maternal exposure to vinblastine during pregnancy: a case report and review.

Front Pediatr

December 2024

Department of Neonatology, Khoo Teck Puat-National University Children Medical Institute, National University Health System, Singapore, Singapore.

Background: Vinblastine is a widely used chemotherapeutic agent for various cancers. We report a case of transient congenital hypothyroidism following maternal exposure to vinblastine during the third trimester of pregnancy and propose possible mechanisms of action.

Method: We utilized the CARE guidelines to report the case.

View Article and Find Full Text PDF

A protein corona is present on any nanoparticle (NP) entering biological fluids; however, the existence of a natural protein corona on natural NPs has not been experimentally confirmed. We used our previously developed photomodification method to fix the natural corona on "biological nanoparticles" (bio-NPs) in fetal bovine serum and newborn bovine serum; native sera served as a control. To isolate photomodified bio-NPs, we used ultracentrifugation (UC), sucrose gradient (12%, 30%, and 50%), and sucrose cushion (30%) methods.

View Article and Find Full Text PDF

PLK1 inhibition impairs erythroid differentiation.

Front Cell Dev Biol

December 2024

School of Life Sciences, Zhengzhou University, Zhengzhou, China.

Polo-like kinase 1 (PLK1), a key regulator of the G2/M phase in mitosis, is frequently overexpressed in numerous tumors. Although PLK1 inhibitors have emerged as promising therapeutic agents for cancer, their use has been linked to significant anemia in a subset of patients, yet the underlying mechanisms remain poorly understood. In this study, we utilized an human umbilical cord blood-derived CD34 cell-based erythroid differentiation system, alongside a murine model, to investigate the impact of PLK1 inhibitors on erythropoiesis.

View Article and Find Full Text PDF

Background: Endovascular abdominal aneurysm repair (EVAR) offers a less invasive approach to treating abdominal aortic aneurysms (AAA) compared to open repair. However, EVAR is associated with higher rates of reintervention. This study investigates the early and mid-term outcomes of patients who underwent late open conversion including aneurysmorrhaphy after EVAR at our institution.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!